Abstract Background and Objective Obstructive airway diseases, including asthma and
Chronic Obstructive Pulmonary Disease (COPD), are two of the most common chronic …

Chronic obstructive pulmonary disease (COPD) can be prevented and treated through
effective care, reducing exacerbations and hospitalizations. Early identification of individuals …

Background: The study developed accurate explainable machine learning (ML) models for
predicting first-time acute exacerbation of chronic obstructive pulmonary disease (COPD …

Background Chronic obstructive pulmonary disease (COPD) poses a large burden on health
care. Severe COPD exacerbations require emergency department visits or inpatient stays …

Importance Clinical guidelines on chronic obstructive pulmonary disease (COPD)
recommend inhalers containing long-acting muscarinic antagonists (LAMAs) and long …

Abstract Chronic Obstructive Lung Disease (COLD) is a continual in ammatory lung disorder
that causes blocked air ow from the lungs. It is also called Chronic Obstructive Pulmonary …

Background: In 2019, the US Food and Drug Administration (FDA) approved the first generic
maintenance inhaler for asthma and chronic obstructive pulmonary disease (COPD). The …

Rationale: Chronic obstructive pulmonary disease (COPD) hospitalizations are a major
burden on patients. Diffusing capacity of the lung for carbon monoxide (DlCO) is a potential …

Background: Demographic and disease characteristics have been associated with the risk of
chronic obstructive pulmonary disease (COPD) exacerbations. Using previously collected …

In 2020, the coronavirus disease (COVID-19) pandemic led to a surge in submissions to
respiratory and critical care journals, but the quality of manuscripts submitted to the …